170 related articles for article (PubMed ID: 1336379)
1. Role of cysteine residues in the extracellular domain and exoplasmic loops of the transmembrane domain of the TSH receptor: effect of mutation to serine on TSH receptor activity and response to thyroid stimulating autoantibodies.
Kosugi S; Ban T; Akamizu T; Kohn LD
Biochem Biophys Res Commun; 1992 Dec; 189(3):1754-62. PubMed ID: 1336379
[TBL] [Abstract][Full Text] [Related]
2. Identification of separate determinants on the thyrotropin receptor reactive with Graves' thyroid-stimulating antibodies and with thyroid-stimulating blocking antibodies in idiopathic myxedema: these determinants have no homologous sequence on gonadotropin receptors.
Kosugi S; Ban T; Akamizu T; Kohn LD
Mol Endocrinol; 1992 Feb; 6(2):168-80. PubMed ID: 1349156
[TBL] [Abstract][Full Text] [Related]
3. Substitutions of different regions of the third cytoplasmic loop of the thyrotropin (TSH) receptor have selective effects on constitutive, TSH-, and TSH receptor autoantibody-stimulated phosphoinositide and 3',5'-cyclic adenosine monophosphate signal generation.
Kosugi S; Okajima F; Ban T; Hidaka A; Shenker A; Kohn LD
Mol Endocrinol; 1993 Aug; 7(8):1009-20. PubMed ID: 7901757
[TBL] [Abstract][Full Text] [Related]
4. Identification of thyroid-stimulating antibody-specific interaction sites in the N-terminal region of the thyrotropin receptor.
Kosugi S; Ban T; Kohn LD
Mol Endocrinol; 1993 Jan; 7(1):114-30. PubMed ID: 8095322
[TBL] [Abstract][Full Text] [Related]
5. Mutation of alanine 623 in the third cytoplasmic loop of the rat thyrotropin (TSH) receptor results in a loss in the phosphoinositide but not cAMP signal induced by TSH and receptor autoantibodies.
Kosugi S; Okajima F; Ban T; Hidaka A; Shenker A; Kohn LD
J Biol Chem; 1992 Dec; 267(34):24153-6. PubMed ID: 1332945
[TBL] [Abstract][Full Text] [Related]
6. Point mutations of the thyrotropin receptor determining structural requirements for its ability to bind thyrotropin and to stimulate adenylate cyclase activity.
Gustavsson B; Westermark B; Heldin NE
Biochem Biophys Res Commun; 1994 Mar; 199(2):612-8. PubMed ID: 8135801
[TBL] [Abstract][Full Text] [Related]
7. Further characterization of a high affinity thyrotropin binding site on the rat thyrotropin receptor which is an epitope for blocking antibodies from idiopathic myxedema patients but not thyroid stimulating antibodies from Graves' patients.
Kosugi S; Ban T; Akamizu T; Kohn LD
Biochem Biophys Res Commun; 1991 Oct; 180(2):1118-24. PubMed ID: 1719963
[TBL] [Abstract][Full Text] [Related]
8. Further studies of amino acids (268-304) in thyrotropin (TSH)--lutropin/chorionic gonadotropin (LH/CG) receptor chimeras: cysteine-301 is important in TSH binding and receptor tertiary structure.
Akamizu T; Inoue D; Kosugi S; Kohn LD; Mori T
Thyroid; 1994; 4(1):43-8. PubMed ID: 8054860
[TBL] [Abstract][Full Text] [Related]
9. The extracellular domain of the TSH receptor has an immunogenic epitope reactive with Graves' IgG but unrelated to receptor function as well as determinants having different roles for high affinity TSH binding and the activity of thyroid-stimulating autoantibodies.
Kosugi S; Akamizu T; Takai O; Prabhakar BS; Kohn LD
Thyroid; 1991; 1(4):321-30. PubMed ID: 1726785
[TBL] [Abstract][Full Text] [Related]
10. Disruption of the first extracellular loop of thyrotropin receptor prevents ligand binding.
Haraguchi K; Saito T; Endo T; Onaya T
Life Sci; 1994; 55(12):961-8. PubMed ID: 7914657
[TBL] [Abstract][Full Text] [Related]
11. Site-directed mutagenesis of a portion of the extracellular domain of the rat thyrotropin receptor important in autoimmune thyroid disease and nonhomologous with gonadotropin receptors. Relationship of functional and immunogenic domains.
Kosugi S; Ban T; Akamizu T; Kohn LD
J Biol Chem; 1991 Oct; 266(29):19413-8. PubMed ID: 1655787
[TBL] [Abstract][Full Text] [Related]
12. Soluble ecto-domain mutant of thyrotropin (TSH) receptor incapable of binding TSH neutralizes the action of thyroid-stimulating antibodies from Graves' patients.
Osuga Y; Liang SG; Dallas JS; Wang C; Hsueh AJ
Endocrinology; 1998 Feb; 139(2):671-6. PubMed ID: 9449640
[TBL] [Abstract][Full Text] [Related]
13. Chimeric studies of the extracellular domain of the rat thyrotropin (TSH) receptor: amino acids (268-304) in the TSH receptor are involved in ligand high affinity binding, but not in TSH receptor-specific signal transduction.
Akamizu T; Inoue D; Kosugi S; Ban T; Kohn LD; Imura H; Mori T
Endocr J; 1993 Jun; 40(3):363-72. PubMed ID: 7920890
[TBL] [Abstract][Full Text] [Related]
14. The thyrotropin (TSH) receptor transmembrane domain mutation (Pro556-Leu) in the hypothyroid hyt/hyt mouse results in plasma membrane targeting but defective TSH binding.
Gu WX; Du GG; Kopp P; Rentoumis A; Albanese C; Kohn LD; Madison LD; Jameson JL
Endocrinology; 1995 Jul; 136(7):3146-53. PubMed ID: 7789342
[TBL] [Abstract][Full Text] [Related]
15. The middle portion in the second cytoplasmic loop of the thyrotropin receptor plays a crucial role in adenylate cyclase activation.
Kosugi S; Kohn LD; Akamizu T; Mori T
Mol Endocrinol; 1994 Apr; 8(4):498-509. PubMed ID: 7914349
[TBL] [Abstract][Full Text] [Related]
16. High affinity binding of thyrotropin (TSH) and thyroid-stimulating autoantibody for the TSH receptor extracellular domain.
Nagayama Y; Takeshita A; Luo W; Ashizawa K; Yokoyama N; Nagataki S
Thyroid; 1994; 4(2):155-9. PubMed ID: 7919997
[TBL] [Abstract][Full Text] [Related]
17. Constitutive activation of the thyrotropin receptor by deletion of a portion of the extracellular domain.
Zhang ML; Sugawa H; Kosugi S; Mori T
Biochem Biophys Res Commun; 1995 Jun; 211(1):205-10. PubMed ID: 7779086
[TBL] [Abstract][Full Text] [Related]
18. The intracellular region adjacent to plasma membrane (residues 684-692) of the thyrotropin receptor is important for phosphoinositide signaling but not for agonist-induced adenylate cyclase activation.
Kosugi S; Mori T
Biochem Biophys Res Commun; 1994 Mar; 199(3):1497-503. PubMed ID: 8147896
[TBL] [Abstract][Full Text] [Related]
19. The third exoplasmic loop of the thyrotropin receptor is partially involved in signal transduction.
Kosugi S; Mori T
FEBS Lett; 1994 Jul; 349(1):89-92. PubMed ID: 8045308
[TBL] [Abstract][Full Text] [Related]
20. Use of thyrotropin receptor (TSHR) mutants to detect stimulating TSHR antibodies in hypothyroid patients with idiopathic myxedema, who have blocking TSHR antibodies.
Kosugi S; Ban T; Akamizu T; Valente W; Kohn LD
J Clin Endocrinol Metab; 1993 Jul; 77(1):19-24. PubMed ID: 8100829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
